NCT04205006 is a clinical trial in Ischemic Stroke, sponsored by Medical University Innsbruck.

Who is sponsoring NCT04205006?

NCT04205006 is sponsored by Medical University Innsbruck.

What condition does NCT04205006 study?

NCT04205006 studies Ischemic Stroke, TIA.

Is NCT04205006 still recruiting?

NCT04205006 is currently status unknown. Last updated 30 August 2022.

Last reviewed 2022-08-30 · How we verify

NCT04205006

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stroke Card Long-term Follow-Up

Status unknown Last updated 30 August 2022

What this trial tests

trial in Ischemic Stroke in 1,000 participants. Status unknown.

Timeline

16 December 2019

Primary endpoint
1 November 2022

1 November 2022

Quick facts

Lead sponsor	Medical University Innsbruck
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	16 December 2019
Primary completion	1 November 2022
Estimated completion	1 November 2022
Sites	2 locations across Austria

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →
TIA — all drugs for TIA →

Sponsor

Medical University Innsbruck

Who can join

18 and older, any sex, with Ischemic Stroke or TIA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We undertook the STROKE-CARD trial (NCT02156778) between 2014 and 2018 with follow-up until 2019 to evaluate the efficacy of the Post-Stroke disease-management program STROKE-CARD care. To further investigate the long-term efficacy of STROKE-CARD care all participants of the original trial will be invited for a Long-term in Person follow-up (3 - 6 years).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Longer term patient management following stroke: A systematic review.
Boehme C, Toell T, Lang W, Knoflach M, et al · · 2021 · cited 35× · PMID 33949269 · DOI 10.1177/17474930211016963
11th European Stroke Organisation Conference Abstracts - 21-23 May 2025, Helsinki, Finland.
· 2025 · cited 3× · PMID 40726475 · DOI 10.1177/23969873251329993
Incidence, characteristics, and consequences of fractures after acute ischemic stroke and TIA-A prospective cohort study.
Karisik A, Dejakum B, Moelgg K, Granna J, et al · · 2025 · cited 2× · PMID 40391684 · DOI 10.1177/17474930251345300
Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol.
Boehme C, Domig L, Komarek S, Toell T, et al · · 2022 · cited 2× · PMID 35915405 · DOI 10.1186/s12872-022-02785-5

Verify or expand the search:

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Medical University Innsbruck trials

Trials by the same sponsor.

NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04205006 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
Last refreshed: 30 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04205006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing